Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,948 total articles
Dave & Buster's (PLAY) is executing a 'back to basics' turnaround under new leadership. The stock trades at $15.74 with an enterprise value to EBITDA of 5.2 and market cap of ~$546M. A disciplined entry at $15.50 with a $13 stop and $25 target offers asymmetric risk/reward if management stabilizes comps and margins.
Arista reported stronger-than-expected Q4 results and gave confident Q1 revenue guidance. With AI networking demand still accelerating and cloud customers shifting toward Ethernet, revenue growth should re-accelerate later in 2026. The trade here is a long position sized to a plan with a clear entry, stop and target tied to margin recovery and orde…
Aquestive plunged on an FDA letter that identified deficiencies in the Anaphylm NDA but confirmed review remains ongoing. The underlying biology, patents, and a recent funding line argue the program is viable; the stock now trades like a binary gamble. This trade idea lays out a mid-term, event-driven long with entry, stop, and target levels, and a…
Safran's aftermarket business is accelerating, margins are improving, and momentum indicators are bullish. With elevated short interest and constructive technicals, we upgrade to Strong Buy and recommend entering at $404.11 with a $480 target and a $368 stop. We expect the trade to play out over the next 180 trading days as recurring services and m…
Danaos (DAC) looks cheap on headline multiples and has a $4.3B contracted backlog and strong charter coverage for 2026. Management's $90 per-share special dividend and an announced stake in the Alaska LNG project complicate the capital-allocation picture. This trade favors a disciplined long exposure that expects the market to look past a temporary…
Build-A-Bear (BBW) has shifted from turnaround to growth, delivering record revenue and stronger margins while sitting on a clean balance sheet and healthy free cash flow. With a market cap near $660M, PE around 11x, and an oversold technical backdrop, I like a controlled long swing trade that targets continued franchise rollouts, commercial/licens…
Ocular has signaled that AXPAXLI, its wet-AMD program, is moving toward a potential NDA filing. That development makes the stock an actionable buy for traders who can tolerate clinical-stage binary risk. The trade below balances upside to regulatory success with a conservative stop to limit downside from filing delays, safety flags, or commercial r…
Fastly ripped higher after a clean Q4 beat and bullish 2026 guide. The market is re-pricing edge infrastructure as an AI growth story; with strong volume, a shrinking float hangover and clear upside to former resistance, Fastly looks like a high-conviction swing trade. Entry, stop and target provided with a 45-trading-day plan and explicit risk con…
<p>AppLovin (APP) has come off its highs but still carries premium multiples. That said, its free cash flow generation and AI-driven ad stack give it a structural advantage that justifies a tactical long entry on this pullback. We use a simple 'Rule of 150' EV/FCF threshold as a sanity check: APP's EV-to-FCF (~40x) comfortably clears that bar. Pair…
Nvidia's leadership in GPUs and data-center networking, combined with massive free cash flow and low leverage, make the stock a compelling tactical long. Technicals are constructive, short-interest is modest relative to liquidity, and upcoming developer and earnings catalysts offer asymmetric upside. Trade plan offers defined entry, target and stop…
Alibaba shares sit on near-term technical support around $154.76 heading into the company's 02/19/2026 earnings. Fundamentals show a large-cap, profitable platform with a $377.3B market cap, P/E of 20.8 and accelerating AI-related capital spending and strategic moves (T-Head spin-off) that could re-rate the stock if execution and cloud momentum rem…
PayPal trades like a mature payments incumbent that briefly forgot how to trade like one. At roughly $41, shares offer exposure to a large digital-payments network at about 7x earnings, positive free cash flow and a balance sheet that can support optionality. The trade: buy into the oversold dip, keep a tight stop below the recent support band, and…
Genpact has been executing a transformation toward higher-value digital services while generating robust cash flow and attractive returns on capital. At $37.62 the stock offers a favorable risk/reward: steady free cash flow ($649M), EPS of $3.24 and a P/E of ~12 imply re-rating potential if growth and margin leverage continue. Technicals show short…
Novo Nordisk (NVO) has been punished by accelerating competition and pricing pressure in the GLP-1/obesity market. At $49.20 the stock prices in a deep growth scare and a guidance cut, but the business still generates meaningful cash flow, pays a 2.48% dividend and controls valuable franchises. This trade idea lays out a mid-term (45 trading days) …
Zscaler has been sold off in a broader SaaS/AI rotation, but the company's market position in zero-trust, healthy free cash flow, and recent product/corporate moves create an asymmetric reward profile. This is a tactical long for the mid term (45 trading days) with a clear entry, stop, and target tied to fundamentals and technical oversold indicato…
FANUC's core factory automation and robot franchises are benefiting from reshoring, automotive electrification and a multi-year robotics upcycle. Technicals show price already above the 50-day and 20-day averages, and market sentiment is improving. We present a disciplined, actionable long with clear entry, stop and target, and a mid-term horizon t…
GSK punched through to a new 52-week high after a strong quarter, dividend lift and EU approval of Exdensur for severe asthma. Fundamentals and guidance point to steady 2026 growth while technical momentum supports a swing trade. Entry at $60.75 with a $67 target offers ~10% upside with a dividend yield buffer of ~2.84%.
Affirm (AFRM) has pulled back sharply from its moving averages and looks technically oversold while underlying free cash flow has jumped to $619M. Market cap is roughly $17.0B and the stock trades at a stretched P/E but at a improving cash conversion profile. This trade idea outlines a disciplined long entry, stop, and target for a mid-term swing (…
Hafnia is trading near its 52-week highs on improving technicals, an attractive 5.77% dividend yield and a $3.36B market cap that looks reasonable against a P/E of 10.9 and a PB of 1.44. Recent moves around Hafnia's TORM stake and rising product tanker rates give the company near-term cash and earnings optionality. We lay out a mid-term trade (45 t…
Fastly’s Q4 beat and raised 2026 outlook point to accelerating adoption of AI workloads at the edge. Revenue growth, positive adjusted EPS, improved margins and positive free cash flow justify a bullish swing trade, but the stock carries elevated technical heat and execution risk. Trade plan: enter $17.50, stop $14.00, target $30.00; horizon: mid-t…
Trimble (TRMB) blends positioning hardware, mapping software, and an expanding suite of subscription services that are being amplified by AI and cloud GIS adoption. The stock is trading below its 50-day moving average with technicals showing mild bullish momentum. This trade idea takes a mid-term long stance with an entry at $66.00, a stop at $61.0…
Northrop Grumman (NOC) combines a near-monopoly in select aerospace and space manufacturing with steady free cash flow and a growing dividend. Recent Q4 strength and a declared $2.31 quarterly dividend suggest disciplined capital allocation, but 2026 guidance showing only 4% sales growth and flat FCF keeps upside measured. This trade idea proposes …
Amazon just retraced to $200 after a sell-off that erased a year of gains. Fundamentals still show a dominant AWS margin engine, healthy returns on equity, and a fortress-like balance sheet. The market is pricing in prolonged weakness; we view today's drop as a tactical buying opportunity with defined risk and a clear target: get long on a measured…
Sibanye-Stillwater (SBSW) trades at $16.06 with a market cap near $11.4B after a dramatic recovery from 2025 lows. With platinum fundamentals tightening, cost cuts underway and short interest concentrated, we upgrade to a tactical long swing: entry $15.90, stop $14.20, target $20.00 over a mid-term (45 trading days) horizon.
ATN announced the sale of a 214-tower U.S. portfolio for up to $297M on 02/11/2026, with expected initial closing in Q2 2026 and $250-270M in gross proceeds. While closing and approvals are not guaranteed and the asset sale reduces revenue and EBITDA, the cash proceeds materially de-lever the business and support a re-rate. We favor a mid-term long…
